Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Focus on Sickle Cell Research -

Focus on Sickle Cell Research

Ralph L Plasmar (Herausgeber)

Buch | Softcover
249 Seiten
2004
Nova Biomedical (Verlag)
978-1-59033-920-6 (ISBN)
CHF 279,60 inkl. MwSt
  • Versand in 3-4 Wochen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Sickle cell anaemia is an inherited blood disorder, characterised primarily by chronic anaemia and periodic episodes of pain and occurring in approximately 1 in every 400 African-American infants born in the United States each year. Individuals of Mediterranean, Arabian, Caribbean, South and Central American, and East Indian ancestry can also be affected. The underlying problem involves haemoglobin, a component of the red cells in the blood. The haemoglobin molecules in each red blood cell carry oxygen from the lungs to the body organs and tissues and bring back carbon dioxide to the lungs. In sickle cell anaemia, the haemoglobin is defective. After the haemoglobin molecules give up their oxygen, some of them may cluster together and form long, rod-like structures. These structures cause the red blood cells to become stiff and to assume a sickle shape. Unlike normal red cells, which are usually smooth and donut-shaped, the sickled red cells cannot squeeze through small blood vessels. Instead, they stack up and cause blockages that deprive the organs and tissue of oxygen-carrying blood. This process produces the periodic episodes of pain and ultimately can damage the tissues and vital organs and lead to other serious medical problems. Unlike normal red blood cells, which last about 120 days in the bloodstream, sickled red cells die after only about 10 to 20 days. Because they cannot be replaced fast enough, the blood is chronically short of red blood cells, a condition called anaemia. Sickle cell anaemia is caused by an error in the gene that tells the body how to make haemoglobin. The defective gene tells the body to make the abnormal haemoglobin that results in deformed red blood cells. This book gathers the latest research in this important field.

Ralph L Plasmar, Editor

Contents: Preface; Energy and Protein Metabolism in Sickle Cell Disease: Evidence of Aberrations; Cerebral Vasculopathy in Sickle Cell Anaemia: Diagnosis, Therapeutic Clinical Trials and the Potential for Prevention; Stroke in Sickle Cell Anaemia; Stroke in Sickle Cell Disease; Sickle Cell Disease and Stroke: Using Transcranial Dopplers and Other Neurodiagnostics Tests to Protect the Brain; Sickle Cell Crisis and Malaria, The Band 3 Connection; Multiple Myeloma in Sickle Cell Syndromes; Sickle Cell Haemoglobinopathy and Sudden Death; Global Left Ventricular Performance in Sickle Cell Anemia During Childhood as Determined by Echocardiography; Sickle Cell Disease: Laboratory Investigations and Haemoglobin Study; Renal Medullary Carcinoma: The Seventh Sickle Cell Nephropathy; Sickle Cell Disease: Introducing a Distinct Elastic Tissue Defect Associated With Inherited Haemolytic Syndromes; IK Channels, A Molecular Target for Inhibition of Erythrocyte Dehydration in Sickle Cell Anaemia; Effect of G6PD Deficiency Upon Sickle Cell Anemia as Reflected By Erythrocytes Pyridine Nucleotide Redox Potential; Oral Health Status and Anthropometric Findings in Sickle Cell Disease; Index.

Erscheint lt. Verlag 14.10.2004
Zusatzinfo Illustrations
Sprache englisch
Maße 260 x 180 mm
Gewicht 738 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
ISBN-10 1-59033-920-7 / 1590339207
ISBN-13 978-1-59033-920-6 / 9781590339206
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95